Dalfampridine as a promising agent in the management of hereditary spastic paraplegia: A triple-blinded, randomized, placebo-controlled pilot trial

Meyyazhagan, 2022, The Puzzle of Hereditary Spastic Paraplegia: From Epidemiology to Treatment, Int J Mol Sci, 23, 7665, 10.3390/ijms23147665 Shribman, 2019, Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches, Lancet Neurol, 18, 1136, 10.1016/S1474-4422(19)30235-2 de Souza, 2017, Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks, Cerebellum, 16, 525, 10.1007/s12311-016-0803-z Cunha, 2022, Hereditary spastic paraparesis: The real-world experience from a Neurogenetics outpatient clinic, Eur J Med Genet, 65, 10.1016/j.ejmg.2022.104430 Lo Giudice, 2014, Hereditary spastic paraplegia: Clinical-genetic characteristics and evolving molecular mechanisms, Exp Neurol, 261, 518, 10.1016/j.expneurol.2014.06.011 Bellofatto, 2019, Management of hereditary spastic paraplegia: a systematic review of the literature, Front Neurol, 10, 3, 10.3389/fneur.2019.00003 Margetis, 2014, Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia, Clin Neurol Neurosurg, 123, 142, 10.1016/j.clineuro.2014.05.024 Heetla, 2015, Improved gait performance in a patient with hereditary spastic paraplegia after a continuous intrathecal baclofen test infusion and subsequent pump implantation: a case report, Arch Phys Med Rehabil, 96, 1166, 10.1016/j.apmr.2015.01.012 Pease, 1998, Therapeutic electrical stimulation for spasticity: quantitative gait analysis, Am J Phys Med Rehabil, 77, 351, 10.1097/00002060-199807000-00021 Seo, 2015, Robot-assisted gait training in a patient with hereditary spastic paraplegia, PM R, 7, 210, 10.1016/j.pmrj.2014.09.008 Samuel, 2013, Physical therapy interventions for the patients with hereditary spastic paraparesis. An exploratory case reports, Int J Physioth Res, 3, 110 Zhang, 2014, The effect of hydrotherapy treatment on gait characteristics of hereditary spastic paraparesis patients, Gait Posture, 39, 1074, 10.1016/j.gaitpost.2014.01.010 Diniz de Lima, 2021, Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial, Mov Disord, 36, 1654, 10.1002/mds.28523 Schöls, 2017, Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial, Brain, 140, 3112, 10.1093/brain/awx273 Judge, 2006, Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment, Pharmacol Ther, 111, 224, 10.1016/j.pharmthera.2005.10.006 Blight, 1989, Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury, Brain Res Bull, 22, 47, 10.1016/0361-9230(89)90126-3 Goodman, 2010, A phase 3 trial of extended release oral dalfampridine in multiple sclerosis, Ann Neurol, 68, 494, 10.1002/ana.22240 Béreau, 2015, Dalfampridine in hereditary spastic paraplegia: a prospective, open study, J Neurol, 262, 1285, 10.1007/s00415-015-7707-6 Uygunoglu, 2016, The Effects of Dalfampridine on Hereditary Spastic Paraparesis, Eur Neurol, 76, 152, 10.1159/000449375 Rosário, 2019, Symptomatic treatment of hereditary spastic paraplegias with fampridine: a pilot study [abstract], Mov Disord, 34 Meyyazhagan A, Orlacchio A. Hereditary Spastic Paraplegia: An Update. Int J Mol Sci. 2022;23. Coleman, 2012, Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis, Curr Med Res Opin, 28, 49, 10.1185/03007995.2011.639752 Podsiadlo, 1991, The timed “Up & Go”: a test of basic functional mobility for frail elderly persons, J Am Geriatr Soc, 39, 142, 10.1111/j.1532-5415.1991.tb01616.x Jones, 1999, A 30-s chair-stand test as a measure of lower body strength in community-residing older adults, Res Q Exerc Sport, 70, 113, 10.1080/02701367.1999.10608028 Corkery, 2007, Establishing normal values for lower extremity muscle length in college-age students, Phys Ther Sport, 8, 66, 10.1016/j.ptsp.2006.11.004 Meseguer-Henarejos, 2018, Inter- and intra-rater reliability of the Modified Ashworth Scale: a systematic review and meta-analysis, Eur J Phys Rehabil Med, 54, 576, 10.23736/S1973-9087.17.04796-7 De Winter, 2013, Using the Student's t-test with extremely small sample sizes, Pract Assess Res Eval, 18, 10 Zhang, 2021, Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials, Orphanet J Rare Dis, 16, 87, 10.1186/s13023-021-01694-8 Shumway-Cook, 2000, Predicting the Probability for Falls in Community-Dwelling Older Adults Using the Timed Up & Go Test, Phys Ther, 80, 896, 10.1093/ptj/80.9.896 Schüle, 2006, The Spastic Paraplegia Rating Scale (SPRS), Neurology, 67, 430, 10.1212/01.wnl.0000228242.53336.90